Agilent Technologies, Inc. $A Shares Sold by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 80.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 27,498 shares of the medical research company’s stock after selling 113,321 shares during the period. Rockefeller Capital Management L.P.’s holdings in Agilent Technologies were worth $3,245,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Resona Asset Management Co. Ltd. increased its stake in shares of Agilent Technologies by 6.2% during the second quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock valued at $11,631,000 after acquiring an additional 5,767 shares during the period. TrueMark Investments LLC bought a new stake in shares of Agilent Technologies in the 2nd quarter worth $1,999,000. Fenimore Asset Management Inc lifted its holdings in shares of Agilent Technologies by 2.7% in the second quarter. Fenimore Asset Management Inc now owns 180,880 shares of the medical research company’s stock valued at $21,346,000 after buying an additional 4,823 shares during the period. Nuance Investments LLC boosted its stake in Agilent Technologies by 13.5% during the second quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock valued at $9,523,000 after buying an additional 9,628 shares in the last quarter. Finally, Carmel Capital Partners LLC grew its holdings in Agilent Technologies by 32.3% during the second quarter. Carmel Capital Partners LLC now owns 10,928 shares of the medical research company’s stock worth $1,290,000 after acquiring an additional 2,667 shares during the period. 87.41% of the stock is currently owned by institutional investors.

Agilent Technologies Stock Up 4.4%

Shares of NYSE:A opened at $151.49 on Friday. The firm has a 50 day simple moving average of $139.65 and a 200 day simple moving average of $125.24. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. The company has a market cap of $42.95 billion, a PE ratio of 35.56, a price-to-earnings-growth ratio of 4.67 and a beta of 1.29.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the previous year, the business earned $1.32 EPS. The company’s revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be paid a $0.255 dividend. The ex-dividend date is Tuesday, January 6th. This represents a $1.02 annualized dividend and a yield of 0.7%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s dividend payout ratio (DPR) is currently 23.94%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on A shares. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. Rothschild & Co Redburn started coverage on shares of Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price on the stock. Robert W. Baird raised their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a report on Thursday, August 28th. JPMorgan Chase & Co. upped their price target on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Finally, Wells Fargo & Company raised their price objective on Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research note on Monday, September 15th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $149.62.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 12,490 shares of the stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the completion of the sale, the chief executive officer directly owned 33,448 shares in the company, valued at approximately $5,017,200. This trade represents a 27.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.26% of the stock is currently owned by corporate insiders.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.